At a glance

ClinicalIndex Comparison Record

N/ACompleted· 15 enrolled

Drug / intervention

transcranial direct current stimulationdevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02975973

NCT02975973N/ACompleted

Compare CT.gov

Prefrontal Cortical Engagement Through Non-Invasive Brain Stimulation in Schizophrenia

Baylor College of Medicine·interventional·Posted Nov 29, 2016·Updated Nov 25, 2020

In Brief

A clinical study evaluating transcranial direct current stimulation for Schizophrenia and Psychosis. Completed, enrolled 15 participants across 1 site.

Detailed Summary

Cognitive impairments in schizophrenia are the most debilitating aspect of the illness and poorly treated by current medications. This study investigates transcranial direct current stimulation (tDCS) - a safe, noninvasive weak electrical current delivery to stimulate brain function - as a novel therapeutic for cognition in schizophrenia. Integrating neurostimulation, electrophysiology and neuroimaging, this project aims to study tDCS effects on cognition by verifying therapeutic target engagement, evaluating the tolerability of tDCS sessions, and optimizing treatment parameters.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsSchizophrenia, Psychosis

CountriesUnited States

CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished

2017201820192020202120222023202420252026

Enrollment StartNov 2016

First PostedNov 2016

Primary CompletionJun 2019

TodayJul 2026

First PostedNov 29, 2016

Enrollment StartNov 1, 2016

Primary CompletionJun 1, 2019

TodayJul 2, 2026

Enrollment to primary: 2.6 yearsPosted 9.6 years ago

Interventions

transcranial direct current stimulationdevice

transcranial direct current stimulation (tDCS) is a safe, noninvasive, weak electrical current delivery that stimulates brain function. It is a novel therapeutic for cognition in schizophrenia.